Findings in the paper published in Nature on 5th March 2025, show that drugs that inhibit cyclooxygenase 1 (COX-1), enhance immunity to cancer metastasis by releasing T cells from suppression, essentially providing the ability for the body’s immune system to stop the spread of cancer.
Link: Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity | Nature
Contact Details
If you are an individual who is interested in taking part in Add-Aspirin, please talk to your doctor who will be able to consider whether you are suitable for the trial.
For healthcare professionals
Please log into the members area for Add-Aspirin contact details.
Register Interest
For healthcare professionals
If your centre would like to recruit participants to Add-Aspirin, contact us:
mrcctu.add-aspirin@ucl.ac.uk
From Monday 16th March 2020, to RANDOMISE a participant in the UK please call +44 (0)20 7670 4925, rather than the usual randomisation line.
To RANDOMISE a participant from Republic of Ireland or India only, please use the 'Register a participant' link above to randomise online. Please make sure to press 'Randomise' once logged in to the server.
Unblind a participant in the UK